APSARD’s Lenard A. Adler, MD is featured in a recent New York Post article exploring whether GLP-1 medications like Ozempic could influence ADHD symptoms. While early reports are intriguing, Dr. Adler explains why more research is needed before these medications can be considered part of ADHD treatment.
Read more: https://nypost.com/2026/06/10/health/ozempic-may-be-a-secret-weapon-against-adhd/
Ask ChatGPT